You’re deep in the trenches of the market. The storm of soaring prices may brew unease, but fret not – a treasure trove of value awaits in these modestly priced stocks. As the market ebbs and flows post-pandemic, there remains a beacon of hope for the discerning investor.
A vast expanse of trading opportunities lay ahead, with over 10,000 companies available for the taking, even beyond the conventional exchanges. The lure of hidden gems beckons, promising untapped potential in the world of value stocks under $20. Here are three such stocks worth your scrutiny.
Hudson Technologies: A Cool Proposition in a Sizzling Market
Source: undefined undefined / Getty Images
Enter Hudson Technologies (NASDAQ:HDSN), a relatively obscure player among the value stocks under $20. Specializing in solutions for refrigeration woes, this company deals in refrigerants, industrial gases, and refrigerant management services. While HDSN may have slipped nearly 14% since the year commenced, it is not a ship lost at sea. In the past year, its shares swelled by close to 49%, demonstrating the potential for a bountiful future.
Trading at a forward earnings multiple of 10.71X, below the industry median of 16.51X, Hudson stands as a beacon of affordability in turbulent waters. Analysts, in unison, tout HDSN as a strong buy, with a target price of $15.50, beckoning intrepid investors to set sail towards potential riches.
Lincoln Educational Services: A Lesson in Investment Potential
Source: fizkes / Shutterstock.com
For those seeking to invest in knowledge, Lincoln Educational Services (NASDAQ:LINC) offers a curriculum in value. Positioned in the realm of career-oriented post-secondary education, Lincoln equips students with professional certifications and degrees in diverse fields. Although LINC may have only nudged up 2% since the year’s dawn, its appeal lies in a modest trailing-year earnings multiple of 11.76X, undercutting the industry median of 19.63X.
Analysts forecast revenue growth, tipping the scales at a potential $435.6 million in fiscal 2025. The optimistic outlook, with a high-side estimate of $449.1 million, paints a picture of promise on a canvas of potential. The unanimous strong buy rating associated with LINC, coupled with an average price target of $13.13, serves as a siren’s call to savvy investors.
VAALCO Energy: A Crude Awakening for Investors
Source: Golden Dayz / Shutterstock.com
Buckle up for a wild ride with VAALCO Energy (NYSE:EGY). Specializing in the acquisition, exploration, and production of oil and gas, this independent energy company offers investors a slice of the energy landscape in countries like Gabon, Egypt, Equatorial Guinea, and Canada.
With a diversified portfolio covering crude oil, natural gas, and natural gas liquids, VAALCO Energy beckons investors seeking a fiery addition to their portfolio. EGY’s prospects burn bright, with analysts envisioning a robust upside, projected revenues of $435.6 million in fiscal 2025. A unanimous strong buy rating and an average price target of $13.13 underscore the untapped potential that awaits investors bold enough to navigate these uncharted investment waters.
Exploring Treasure Troves: A Dive into the World of Value Stocks
A Glance at Vaalco Energy (EGY)
Vaalco Energy (NYSE:EGY) has been venturing into the lucrative Etame Marin block, with the Etame production-sharing contract holding sway over approximately 46,200 gross acres. Investors have been keeping a watchful eye on EGY due to its attractive valuation metrics. Trading at a PEG ratio of 0.28, significantly lower than the sector average of 0.99X, and a forward earnings multiple of 7.86X, below the oil and gas sector’s median of 9.68X, the company is drawing in value investors with promising prospects.
Although Vaalco experienced a rocky earnings path in fiscal 2023, a notable turnaround was observed in Q4, where the company exceeded EPS expectations significantly. Despite apprehensions about the future of the hydrocarbon industry, analysts are unanimously backing EGY with a strong buy rating. With a forward-12-month price target of $8.54, suggesting a potential upside of over 39%, Vaalco Energy is shining bright among investors eyeing value.
Unveiling Galiano Gold (GAU)
Galiano Gold (NYSEAMERICAN:GAU) has been turning heads with its exploration and evaluation of gold properties, particularly its flagship asset, the Asanko Gold Mine, sprawled over approximately 21,000 hectares in Ghana, West Africa. The stock of GAU has surged over 21% since the beginning of the year, making it an intriguing prospect for investors seeking value stocks under $20.
The attractiveness of Galiano lies in its modest trailing-year earnings multiple of 4.26X, lower than the majority of players in the metals and mining industry, which boast a median ratio of 16.31. Additionally, GAU trades at an EV-to-EBITDA ratio of 3.78, below the sector median of 8.83X, adding another layer of allure for value investors. Despite a tumultuous earnings performance in the past year, experts foresee a significant growth trajectory for Galiano, with sales projected to reach $331.65 million, marking a 29.3% increase from the previous year.
TransAlta (NYSE:TAC) is charting a course through the utilities sector as an independent power producer, specializing in the development, production, and sale of electric energy. With segments spanning Hydro, Wind and Solar, Gas, Energy Transition, and Energy Marketing, the company has seen a dip of nearly 23% in market value since the year commenced.
While the decline may paint a risky picture for potential investors, the metrics present an enticing proposition. TAC boasts a PEG ratio of 0.33, contrasting sharply with the utilities subsegment’s median ratio of 1.51X. Moreover, the trailing-year earnings multiple of 3.74X for TransAlta is well below the sector median of 15.55X, creating an attractive entry point for value-focused speculators.
Although growth concerns loom on the horizon with projected sales anticipated to drop by 19.6% to $1.99 billion, analysts remain bullish on the stock. With an average price target of $11.19, suggesting a potential growth of over 77%, TransAlta presents a bold opportunity for those willing to weather the storm.
Embarking on the Odyssey with Voyager Therapeutics (VYGR)
Voyager Therapeutics (NASDAQ:VYGR) sets sail in the vast sea of biotechnology, focusing on gene therapy and neurological disease treatment. With VY-TAU01, an anti-tau antibody program aimed at addressing Alzheimer’s disease, Voyager’s therapeutic pursuits navigate challenging waters.
Despite the inherent rigors of its therapeutic focus, Voyager Therapeutics presents an intriguing opportunity for investors seeking value. With each company showcasing unique value propositions and growth potential, these stocks offer a diverse range of investment opportunities for those willing to delve into the depths of value investing.
Unlocking the Potential in VYGR and IQ for Savvy Investors
Voyager Therapeutics (VYGR)
As Voyager Therapeutics (VYGR) blazes through the clinical stage like a comet in the night sky, investors are buzzing with excitement. The stock has surged by an impressive 15% since the dawn of the new year, marking a significant uptick in the past 52 weeks by 33%. But here’s the kicker – VYGR is trading at a mere 3.42X trailing-year earnings and 1.84X trailing-year revenue, way below the industry averages of 29.53X and 9.52X, respectively. Why the rock-bottom valuation, you ask?
While projections hint at a potential loss in 2024 and a dip in revenue to the tune of $39.82 million, last year’s earnings per share stood strong at $2.97, with sales hitting $250 million. The real gamble, however, lies in the realm of science.
Analysts have sung a harmonious chorus of strong buy recommendations for VYGR, forecasting a price per share of $16.33. If this prophecy holds true, brace yourself for a meteoric 76% surge.
iQIYI (IQ)
Source: NYC Russ / Shutterstock.com
iQIYI (IQ), nestled in the bustling streets of China, serves up online entertainment videos with the finesse of a seasoned chef. Yet, with shares backpedaling by over 13% this year and a staggering 40% nosedive in the past 12 months, IQ is akin to a treasure chest waiting to be discovered – or a Pandora’s box of risk.
Concerns surrounding the state of the Chinese economy cast a looming shadow, making IQ a daring choice for value seekers in the sub-$20 category. At just 2.19X forward earnings multiple, IQ sits well below the industry norm of 13.1X. Additionally, its PEG ratio of 0.9X dances gracefully below the sector’s median of 1.28X.
Recent earnings reports for Q2 and Q3 saw IQ exceeding expectations with 5 cents and 7 cents per share, respectively. Q4 kicked things up a notch, delivering 7 cents EPS against a target of 6 cents. Looking ahead to 2024, per-share profits are forecasted to leap to 41 cents, beating out last year’s 28 cents.
The verdict from analysts? A resounding chorus of strong buy ratings, with a dazzling $6.43 price target that could yield a princely 61% return on your investment.
On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are solely those of the writer, adhering to the InvestorPlace.com Publishing Guidelines.
